Carregant...
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
The sites of targeted therapy are limited and need to be expanded. The FGF‐FGFR signalling plays pivotal roles in the oncogenic process, and FGF/FGFR inhibitors are a promising method to treat FGFR‐altered tumours. The VEGF‐VEGFR signalling is the most crucial pathway to induce angiogenesis, and inh...
Guardat en:
| Publicat a: | Cell Prolif |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016646/ https://ncbi.nlm.nih.gov/pubmed/33655556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.13009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|